help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lanken, P. N.
Right arrow Articles by Fishman, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lanken, P. N.
Right arrow Articles by Fishman, A. P.

American Journal of Pathology, Vol 99, 561-588, Copyright © 1980 by American Society for Investigative Pathology


REGULAR ARTICLES

Alveolar response to experimental Pneumocystis carinii pneumonia in the rat

PN Lanken, M Minda, GG Pietra and AP Fishman

In order to characterize the alveolar response to Pneumocystis carinii pneumonia, light and electron miscropy were used to trace the development of experimental infections with P carinii in rats treated with cortisone acetate and a low-protein diet. The first changes were found by the eighth day of treatment and consisted of the selective attachment of Pneumocystis organisms, mostly trophozoites, to alveolar Type 1 pneumocytes; the host cells were undamaged, and no inflammatory response was seen. After approximately one month of treatment, the seemingly innocuous host-parasite interaction was succeeded by focal necrosis of the Type 1 pneumocytes adjacent to organisms; hyperplasia of nearby Type 2 pneumocytes also occurred, to replace the dead Type 1 pneumocytes. Even at this stage, inflammatory reaction was conspicuously absent except for occasional alveolar macrophages in the diseased alveoli; in addition, all cells of the alveolar-capillary membrane other than Type 1 pneumocytes appeared entirely normal. Not only does the present study clarify the nature of alveolar injury caused by Pneumocystis carinii, but it also provides an experimental animal model in which selective injury of the alveolar lining cells occurs.


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Wang, F. Gigliotti, S. P. Bhagwat, S. B. Maggirwar, and T. W. Wright
Pneumocystis stimulates MCP-1 production by alveolar epithelial cells through a JNK-dependent mechanism
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1495 - L1505.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Wang, F. Gigliotti, S. Maggirwar, C. Johnston, J. N. Finkelstein, and T. W. Wright
Pneumocystis carinii Activates the NF-{kappa}B Signaling Pathway in Alveolar Epithelial Cells
Infect. Immun., May 1, 2005; 73(5): 2766 - 2777.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
M. E. Lasbury, P. J. Durant, M. S. Bartlett, J. W. Smith, and C.-H. Lee
Correlation of Organism Burden and Alveolar Macrophage Counts during Infection with Pneumocystis carinii and Recovery
Clin. Vaccine Immunol., March 1, 2003; 10(2): 293 - 302.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
G. S. Gilmartin and H. Koziel
Pneumocystis Carinii Pneumonia in Adult Non-HIV Disorders
J Intensive Care Med, November 1, 2002; 17(6): 283 - 301.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
T. W. Wright, C. J. Johnston, A. G. Harmsen, and J. N. Finkelstein
Chemokine Gene Expression during Pneumocystis carinii-Driven Pulmonary Inflammation
Infect. Immun., July 1, 1999; 67(7): 3452 - 3460.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. J. Simpson-Haidaris, M.-A. Courtney, T. W. Wright, R. Goss, A. Harmsen, and F. Gigliotti
Induction of Fibrinogen Expression in the Lung Epithelium during Pneumocystis carinii Pneumonia
Infect. Immun., September 1, 1998; 66(9): 4431 - 4439.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American Society for Investigative Pathology.